NOVEL COMBINATION TREATMENT FOR ACUTE MYELOID LEUKEMIA (AML)

• 收藏
• 分享

专利权人:

发明人:

申请号：

EP14808911.3

公开号：

EP3077004A1

申请日:

2014.12.01

申请国别(地区):

EP

年份:

2016

代理人:

摘要：

The present invention relates to a pharmaceutical product comprising a) as a first component an inhibitor of the MDM2-p53 interaction and b) as a second component cytarabine as a combined preparation for the sequential or simultaneous use in the treatment of cancer, particularly AML.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/